HCA Healthcare (HCA) fundamentals: P/E, valuation, undervalued?
HCA Healthcare · Health Care · ref. ETF XLV · price $460.75
In short — HCA Healthcare trades at 15.4× earnings (P/E), 14.4× forward, with a net margin of 8.8 % and revenue growth of +9 %. Read: Fairly valued (P/E 14 in line with ~12% growth (PEG 1.2)).
Is HCA Healthcare stock cheap or undervalued? A good time to buy? Here are its fundamentals — P/E, PEG, margin and income statement — to judge its valuation.
📈 1-year price
$460.75+10.1% over range
Oct 14, 25low $361.32 · high $545.13Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
67% recommend buying · 18 analysts
Valuation : Fairly valued — P/E 14 in line with ~12% growth (PEG 1.2)
Valuation
15.4
P/E (price/earnings)
14.4
Forward P/E
1.33
PEG
—
Price/book (P/B)
$102.2B
Market cap
29.83
EPS
Profitability & growth
8.8 %
Net margin
+9 %
Revenue growth
+12 %
Earnings growth
$51.6B
Total debt
HCA Healthcare income statement
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| 2022 | $60.2B | $5.6B | 9.4 % |
| 2023 | $65.0B | $5.2B | 8.1 % |
| 2024 | $70.6B | $5.8B | 8.2 % |
| 2025 | $75.6B | $6.8B | 9.0 % |
⚠️ Indicative financial data (Yahoo Finance), not investment advice. Amounts in $.
Frequently asked questions
What is HCA Healthcare's P/E and is the stock undervalued? What's a good P/E?
HCA Healthcare's P/E is 15.4 (forward 14.4). Below ~15 = fairly cheap, above ~30 = expensive. Our valuation verdict: "Fairly valued".
Is HCA Healthcare profitable?
HCA Healthcare has a net margin of 8.8 % (EPS 29.83). The company is profitable.
Is HCA stock expensive?
Our read: "Fairly valued" — P/E 14 in line with ~12% growth (PEG 1.2). Cross-check with growth and sector.
💬 A question about HCA Healthcare? The JPI assistant answers using our backtest data.